Scholarlink

<p>One approach to combating the surge in bacterial antimicrobial resistance is to use adjuvants that sensitize drug-resistant strains to conventional antibiotics. Here, we evaluated 24 pure bioactive compounds for their antibiotic adjuvant activity against a multidrug-resistant strain of <i>Salmonella</i> Typhimurium (DT104). All 24 bioactive compounds exhibited measurable antibacterial activity against DT104, with MIC values ranging from 0.036 to 4&#xa0;mg/mL. Moreover, four bioactive compounds, namely p-coumaric acid, 4-hydroxycinnamic acid, itaconic acid, and cinnamic acid, sensitized DT104 to five antibiotics: ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline. Bioactive compounds, specifically 4-hydroxycinnamic acid and itaconic acid, induced the largest reductions in antibiotic MICs (1024- and 256-fold, respectively). Besides, 4-hydroxycinnamic acid was also synergistic with ciprofloxacin and inhibited the growth of ciprofloxacin-resistant strains of foodborne <i>Salmonella</i> (16-fold). The broad antibiotic adjuvant efficiency of 4-hydroxycinnamic acid was also demonstrated against multidrug-resistant strains of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae.</i> Subsequent checkerboard analysis revealed that bioactive compounds maintained their antibiotic adjuvant activity even at their 0.5 × MIC levels. Subsequent time-kill kinetic studies confirmed the results of the checkerboard analysis. Overall, we demonstrate that 4-hydroxycinnamic and itaconic acid can sensitize drug-resistant bacteria to multiple antibiotics and can function as highly effective antibiotic adjuvants.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

4-Hydroxycinnamic acid and Itaconic acid exhibit broad spectrum synergy with conventional antibiotics in inhibiting multidrug-resistant Salmonella Typhimurium

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月12日

查看全文
  • Bismi Phasaludeen,
  • Hunter Sheffield,
  • Kripa Pancholi,
  • Greeshma Bharathan,
  • Dania Mustafa Darwich,
  • Hina Khan,
  • Priti Mudgil,
  • Ihab Habib,
  • Laura Huber,
  • RJeff Buhr,
  • Akmal Nazir,
  • Shabarinath Srikumar

摘要

One approach to combating the surge in bacterial antimicrobial resistance is to use adjuvants that sensitize drug-resistant strains to conventional antibiotics. Here, we evaluated 24 pure bioactive compounds for their antibiotic adjuvant activity against a multidrug-resistant strain of Salmonella Typhimurium (DT104). All 24 bioactive compounds exhibited measurable antibacterial activity against DT104, with MIC values ranging from 0.036 to 4 mg/mL. Moreover, four bioactive compounds, namely p-coumaric acid, 4-hydroxycinnamic acid, itaconic acid, and cinnamic acid, sensitized DT104 to five antibiotics: ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline. Bioactive compounds, specifically 4-hydroxycinnamic acid and itaconic acid, induced the largest reductions in antibiotic MICs (1024- and 256-fold, respectively). Besides, 4-hydroxycinnamic acid was also synergistic with ciprofloxacin and inhibited the growth of ciprofloxacin-resistant strains of foodborne Salmonella (16-fold). The broad antibiotic adjuvant efficiency of 4-hydroxycinnamic acid was also demonstrated against multidrug-resistant strains of Escherichia coli and Klebsiella pneumoniae. Subsequent checkerboard analysis revealed that bioactive compounds maintained their antibiotic adjuvant activity even at their 0.5 × MIC levels. Subsequent time-kill kinetic studies confirmed the results of the checkerboard analysis. Overall, we demonstrate that 4-hydroxycinnamic and itaconic acid can sensitize drug-resistant bacteria to multiple antibiotics and can function as highly effective antibiotic adjuvants.